Recurrent COVID-19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system?

J Med Virol. 2021 Apr;93(4):1882-1884. doi: 10.1002/jmv.26701. Epub 2020 Dec 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Viral / blood
  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / therapeutic use
  • COVID-19 / complications*
  • Hodgkin Disease* / complications
  • Hodgkin Disease* / drug therapy
  • Humans
  • Immune System / drug effects*
  • Immunoglobulin G / blood
  • Male
  • Reinfection / virology*
  • Risk Factors
  • Seroconversion

Substances

  • Antibodies, Viral
  • Antineoplastic Agents
  • Immunoglobulin G